Table 3.
A. lung cancer | ||||
lung cancer stage | OPNa | OPNb | OPNc | |
correlation coefficient | 0.127 | 0.172 | 0.185 | |
p-value | 0.480 | 0.339 | 0.304 | |
lung cancer size | OPNa | OPNb | OPNc | |
correlation coefficient | -0.193 | -0.508 | -0.012 | |
p-value | 0.259 | 0.002 | 0.942 | |
B. breast cancer | ||||
breast cancer stage T | OPNa | OPNb | OPNc | |
correlation coefficient | 0.223 | 0.123 | 0.087 | |
p-value | 0.084 | 0.343 | 0.507 | |
breast cancer stage N | OPNa | OPNb | OPNc | |
correlation coefficient | 0.078 | -0.084 | 0.161 | |
p-value | 0.561 | 0.530 | 0.227 | |
breast cancer size | OPNa | OPNb | OPNc | |
correlation coefficient | -0.070 | -0.090 | 0.111 | |
p-value | 0.585 | 0.480 | 0.385 |
To determine the relationship between osteopontin splice variant levels and tumor stage or primary tumor size, Spearman’s correlation coefficient and its associated p-value were calculated. For lung cancers (A), stage I-IV was used (n = 10, 6, 11, 6 for I, II, II, IV). For breast cancers (B), stage T (n = 37, 16, 8, 2 for T1, T2, T3, T4) and N (n = 28, 20, 5, 7, 0 for N0, N1, N2, N3, N4) were applied to the analysis. Of note, the significant p-value is not reflective of a strong correlation. It indicates that the population correlation coefficient is different than zero with the degree of confidence given by the p-value.